The Non-Malignant Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASH 2023 | The risk of bleeding in patients with von Willebrand disease hospitalized due to AMI
Orly Leiva, MD, NYU Langone Health, New York City, NY, discusses the risk of post-hospitalization bleeding in patients with von Willebrand disease (VWD) who have experienced acute myocardial infarction (AMI). Retrospective analyses have determined that the risk of bleeding is increased during post-AMI hospitalization in these patients. However, many questions about the chronic management of AMI in VWD remain unanswered. This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
